Nephros, Inc. (NASDAQ:NEPH) Stock Position Decreased by Bard Associates Inc.

Bard Associates Inc. lessened its holdings in shares of Nephros, Inc. (NASDAQ:NEPH) by 9.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 155,271 shares of the company’s stock after selling 17,100 shares during the period. Bard Associates Inc.’s holdings in Nephros were worth $228,000 at the end of the most recent reporting period.

Nephros Stock Down 6.6 %

Nephros stock opened at $1.41 on Tuesday. The firm has a 50-day moving average price of $1.55 and a two-hundred day moving average price of $1.60. The firm has a market capitalization of $14.87 million, a price-to-earnings ratio of -15.67 and a beta of 1.19. Nephros, Inc. has a 52-week low of $1.36 and a 52-week high of $3.19.

Analysts Set New Price Targets

Separately, Benchmark reaffirmed a “speculative buy” rating and set a $5.00 price objective on shares of Nephros in a research report on Tuesday, November 12th.

Nephros Company Profile

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.